Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-057432

Principal Accounting Officer sold 959 shares at $8.87 ($8,506)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PISKEL KYLE Principal Accounting Officer 2022-11-16 Sale −959 $8.87 $8,506 46,706 D
Open-market sales · 959 sh · avg $8.87 · $8,506
Loading xslF345X03/doc4.xml…